Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Atazanavir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atazanavir 100mg capsules
0503010L0AAACAC
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atazanavir 150mg capsules
0503010L0AAAAAA
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atazanavir 200mg capsules
0503010L0AAABAB
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atazanavir 300mg capsules
0503010L0AAADAD
|
Atazanavir | Atazanavir | Infections | No data available |
|
Reyataz 100mg capsules
0503010L0BBACAC
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 150mg capsules
0503010L0BBAAAA
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 200mg capsules
0503010L0BBABAB
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 300mg capsules
0503010L0BBADAD
|
Reyataz | Atazanavir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.